← Leaderboards
Tatsuro Yoshida
New Health Sciences, Inc.
$6,067,826
Attributed
$8,448,203
Total exposure
6
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.5M · FY2007–24$2M$1.5M$1M$500K$0
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$8,448,203 · 6
By mechanism
R44$6,358,937 · 3
N01$1,464,886 · 1
R43$429,253 · 2
N43$195,127 · 1
Top collaborators
- Andrew Dunham3 shared
- Travis Nemkov2 shared
- Moritz Stolla1 shared
Most similar at New Health Sciences, Inc.
Same institution · by research overlap
- Andrew Dunham$1,484,879
Others in their field
Top investigators on “Erythrocytes”
- Walter C. Willett · Harvard University (Sch Of Public Hlth)$59,483,299
- Russell E Ware · Duke University$40,659,016
- Stephen Lev Hoffman · Sanaria, Inc.$25,570,898
- Stefan H.i. Kappe · Seattle Children'S Hospital$24,818,069
- Mark Thomas Gladwin · Clinical Center$21,310,832
- Manoj T Duraisingh · Harvard University D/B/A Harvard School Of Public Health$19,622,648
Research focus
ErythrocytesOxygenBlood BanksTransfusionBloodProceduresLifeBlood TransfusionDesignHemolysisRecoveryEquipmentPerfusionLogisticsBiochemicalDevicesMorphologyHemoglobinCommercializationLesionClinical ResearchMarketingEnvironmentIn Vitro
Grant awards (11)
Hypoxically stored whole blood--evaluation of platelet activities under hypoxic storage conditions$295,963
R43 · FY2024 · HL · contact PI
An additive solution optimized for anaerobic (hypoxic) RBC storage to minimize storage lesion development.$773,178
R44 · FY2021 · HL · contact PI
An additive solution optimized for anaerobic (hypoxic) RBC storage to minimize storage lesion development.$721,856
R44 · FY2020 · HL · contact PI
Regulatory Approval & Commercialization of an RBC Processing and Storage System to Improve Transfusion Therapy by Minimizing Oxidative Damage to RBC during Storage$980,623
R44 · FY2018 · HL · contact PI
Regulatory Approval & Commercialization of an RBC Processing and Storage System to Improve Transfusion Therapy by Minimizing Oxidative Damage to RBC during Storage$997,658
R44 · FY2017 · HL · contact PI
Regulatory Approval & Commercialization of an RBC Processing and Storage System to Improve Transfusion Therapy by Minimizing Oxidative Damage to RBC during Storage$991,476
R44 · FY2016 · HL · contact PI
SBIR Topic 74, Phase I, RBC Storage System to Minimize Storage Lesions$1,464,886
N01 · FY2014 · HL · contact PI
SBIR Topic 74, Phase I, RBC Storage System to Minimize Storage Lesions$195,127
N43 · FY2013 · HL · contact PI
Anaerobically stored red blood cells with extended shelf-life$986,267
R44 · FY2010 · HL · contact PI
Anaerobically stored red blood cells with extended shelf-life$907,879
R44 · FY2009 · HL · contact PI
Anaerobically stored red blood cells with extended shelf-life.$133,290
R43 · FY2007 · HL · contact PI